90 related articles for article (PubMed ID: 18028241)
21. Oxcarbazepine improves mood in patients with epilepsy.
Mazza M; Della Marca G; Di Nicola M; Martinotti G; Pozzi G; Janiri L; Bria P; Mazza S
Epilepsy Behav; 2007 May; 10(3):397-401. PubMed ID: 17300991
[TBL] [Abstract][Full Text] [Related]
22. The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate.
Cansu A; Serdaroğlu A; Camurdan O; Hirfanoğlu T; Bideci A; Gücüyener K
Epilepsia; 2006 Nov; 47(11):1855-9. PubMed ID: 17116024
[TBL] [Abstract][Full Text] [Related]
23. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
[TBL] [Abstract][Full Text] [Related]
24. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode.
Benedetti A; Lattanzi L; Pini S; Musetti L; Dell'Osso L; Cassano GB
J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507
[TBL] [Abstract][Full Text] [Related]
25. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.
Coppola G; Franzoni E; Verrotti A; Garone C; Sarajlija J; Operto FF; Pascotto A
Brain Dev; 2007 Jun; 29(5):281-4. PubMed ID: 17055681
[TBL] [Abstract][Full Text] [Related]
26. Oxcarbazepine as add-on therapy in Thai epileptic patients with refractory partial seizures.
Kraiprab P; Chinvarun Y; Tantisira MH
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S193-201. PubMed ID: 16858958
[TBL] [Abstract][Full Text] [Related]
27. [Characteristics and indications of oxcarbazepine].
Herranz JL; Argumosa A
Rev Neurol; 2002 Sep; 35 Suppl 1():S101-9. PubMed ID: 12373662
[TBL] [Abstract][Full Text] [Related]
28. Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring.
Azar NJ; Wang L; Song Y; Abou-Khalil BW
Epilepsy Res; 2008 Mar; 79(1):78-83. PubMed ID: 18281195
[TBL] [Abstract][Full Text] [Related]
29. Cognitive and psychosocial effects of oxcarbazepine monotherapy in newly diagnosed partial epilepsy.
Kim D; Seo JH; Joo EY; Lee HW; Shin WC; Hong SB
Clin Neuropharmacol; 2014; 37(4):100-7. PubMed ID: 24992084
[TBL] [Abstract][Full Text] [Related]
30. A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients.
Croissant B; Diehl A; Klein O; Zambrano S; Nakovics H; Heinz A; Mann K
Alcohol Clin Exp Res; 2006 Apr; 30(4):630-5. PubMed ID: 16573580
[TBL] [Abstract][Full Text] [Related]
31. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
Vaisleib II; Neft RA
Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
[TBL] [Abstract][Full Text] [Related]
32. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine.
Cansu A; Serdaroglu A; Biberoglu G; Tumer L; Hirfanoglu TL; Ezgu FS; Hasanoglu A
Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044
[TBL] [Abstract][Full Text] [Related]
33. Use of oxcarbazepine for treatment of refractory status epilepticus.
Kellinghaus C; Berning S; Stögbauer F
Seizure; 2014 Feb; 23(2):151-4. PubMed ID: 24295895
[TBL] [Abstract][Full Text] [Related]
34. Oxcarbazepine add-on in the treatment of refractory bipolar disorder.
Pratoomsri W; Yatham LN; Sohn CH; Solomons K; Lam RW
Bipolar Disord; 2005; 7 Suppl 5():37-42. PubMed ID: 16225559
[TBL] [Abstract][Full Text] [Related]
35. Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages.
Misdrahi D; Tournier M; Droulout T; Grolleau A; Titier K; Molimard M; Verdoux H
Eur Psychiatry; 2008 Sep; 23(6):409-12. PubMed ID: 18755575
[TBL] [Abstract][Full Text] [Related]
36. Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.
Mazzucchelli I; Onat FY; Ozkara C; Atakli D; Specchio LM; Neve AL; Gatti G; Perucca E
Epilepsia; 2006 Mar; 47(3):504-9. PubMed ID: 16529613
[TBL] [Abstract][Full Text] [Related]
37. Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal--a RCT.
Croissant B; Loeber S; Diehl A; Nakovics H; Wagner F; Kiefer F; Mann K
Pharmacopsychiatry; 2009 Sep; 42(5):175-81. PubMed ID: 19724979
[TBL] [Abstract][Full Text] [Related]
38. Oxcarbazepine in bipolar disorder: a critical review of the literature.
Mazza M; Di Nicola M; Martinotti G; Taranto C; Pozzi G; Conte G; Janiri L; Bria P; Mazza S
Expert Opin Pharmacother; 2007 Apr; 8(5):649-56. PubMed ID: 17376019
[TBL] [Abstract][Full Text] [Related]
39. Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy.
Ortenzi A; Paggi A; Foschi N; Sabbatini D; Pistoli E
Funct Neurol; 2008; 23(2):97-100. PubMed ID: 18671911
[TBL] [Abstract][Full Text] [Related]
40. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
